Advertisement

Monoclonal (Auto)Antibodies in Insulin-Dependent Diabetes Mellitus

Conference paper
  • 184 Downloads
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 156)

Abstract

Insulin-dependent diabetes mellitus (IDDM) in humans, BB rats (MARLISS 1983), and nonobese diabetic (NOD) mice (MAKINO et al. 1980) is characterized by immune abnormalities leading to self-destruction of the insulin-producing islet β cells. These abnormalities have been observed in the cell-mediated as well as in the humoral immune response. Two major types of auto-antibodies have been reported, namely, islet cell cytoplasmic (ICA; BOTTAZZO et al. 1974; MAUISH et al. 1974) and islet cell surface antibodies (ICSA; LERNMARK et al. 1978). In this chapter we will review data on experimental monoclonal antibodies to islet cells with a special emphasis on autoantibodies derived from the BB rat.

Keywords

Islet Cell Islet Cell Antibody Islet Hormone Insulin Autoantibody Human Insulin Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atkinson MA, Maclaren NK (1988) Autoantibodies in non-obese diabetic mice immunoprecipitate64000 M r islet antigen. Diabetes 37: 1587–1590PubMedCrossRefGoogle Scholar
  2. Bækkeskov S, Christie M 1989 (to be published) Characterization of the 64 KD membrane autoantigen in pancreatic β-cells. Current communications in molecular biology. Proceedings of Cold Spring Habour Laboratory Symposium on β-cells. Cold Spring Harbour Laboratory, USAGoogle Scholar
  3. Bækkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins. Nature 298: 167–169PubMedCrossRefGoogle Scholar
  4. Bækkeskov S, Dyrberg T, Lernmark Å (1984) Autoantibodies against an M r 64 k islet cell protein precede the onset of insulin-dependent diabetes in the BB rat. Science 224: 1348–1350PubMedCrossRefGoogle Scholar
  5. Bazin H (1982) Production of rat monoclonal antibodies with the LOU rat non-secreting IR983F myeloma cell line. In: Peeters H (ed) Protides of the biological fluids. 29th Colloquium 1981. Pergamon, Oxford, pp 615–618Google Scholar
  6. Boitard C, Bendelac A, Richard MF, Carnaud C, Bach JF (1988) Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells Proc Natl Acad Sci USA 85: 9719–9723PubMedCrossRefGoogle Scholar
  7. Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1282PubMedCrossRefGoogle Scholar
  8. Brogren CH, Hirsch F, Wood P, Druet P, Poussier P (1986) Production and characterization of a monoclonal islet cell surface autoantibody from the BB rat. Diabetologia 29: 330–333PubMedCrossRefGoogle Scholar
  9. Bucchini D, Madsen O, Desbois P, Pictet R, Jami J (1989) B islet cells of pancreas are the site of expression of the human insulin gene in transgenic mice. Exp Cell Res 180: 467–474PubMedCrossRefGoogle Scholar
  10. Buschard K, Brogren CH, Röpke C, Rygaard J (1988) Antigen expression of the pancreatic beta-cell is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2. APMIS 96: 342–346PubMedCrossRefGoogle Scholar
  11. Buse IB, Powers A, Mori H, Rabizadeh A, Haynes B, Eisenbarth GS (1983) Anti-islet monoclonal autoantibodies from the BB-rat. Diabetes 32: 51AGoogle Scholar
  12. Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ono K, Kershnar A, Buckingham B, Golden M (1983) Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 130: 1189–1194PubMedGoogle Scholar
  13. Chick WL, Warren S, Chute RN, Like AA, Lauris V, Kitchen KC (1977) A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 74: 628–632PubMedCrossRefGoogle Scholar
  14. Colman PG, Nayak RC, Campbell IL, Eisenbarth GS (1988) Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37: 645–652PubMedCrossRefGoogle Scholar
  15. Contreas G, Madsen OD, Vissing H, Lernmark Å (1986) A simple assay for the detection of antibodies to endocrine islet cell surface antigens. J Immunol Methods 95: 135–139PubMedCrossRefGoogle Scholar
  16. Contreas G, Jørgensen JL, Nielsen E, Madsen OD (1988) Characterization by immunoblotting of autoantigens recognized by autoantibodies derived from prediabetic B-rats. In: Schafer-Nielsen C (ed) Electrophoresis’88. Proceedings. Protein Laboratory, University of Copenhagen, pp 432–439Google Scholar
  17. Contreas G, Jørgensen J, Madsen OD (1989) Novel islet, duct and acinar cell markers defined by monoclonal autoantibodies from prediabetic BB rats. Pancreas (in press)Google Scholar
  18. Croce CM, Linnenbach A, Hall W, Steplewski Z, Koprowski H (1980) Production of human hybridomas secreting antibodies to measles virus. Nature 288: 488–489PubMedCrossRefGoogle Scholar
  19. Dean M, Maker F, Mally JM, Tarn AC, Schwarz G, Gale EAM, Bottazzo GF (1986) Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 29: 339–342PubMedCrossRefGoogle Scholar
  20. Derete GF, Betterle C, Padovan D (1977) Incidence of isletcell autoantibodies in different types of diabetes mellitus. Diabetes 26: 909–915Google Scholar
  21. de St Groth SF, Scheidegger D (1980) Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35: 1–21CrossRefGoogle Scholar
  22. Doberson MJ, Scharff J, Ginsberg-Fellner F, Notkins A (1980) Cytotoxic antibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303: 1493–1498CrossRefGoogle Scholar
  23. Dyrberg T, Poussier P, Nakhooda AF, Marliss EB, Lernmark A (1984) Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia 26: 159–165PubMedCrossRefGoogle Scholar
  24. Eisenbarth GS (1987) Genes, generator of diversity, glycoconjugates, and autoimmune β-cellinsufficiency in type 1 diabetes. Diabetes 36: 355–364PubMedGoogle Scholar
  25. Eisenbarth GS, Linnenbach A, Jackson R, Scearce R, Croce CM (1982) Human hybridomas secreting anti-islet autoantibodies. Nature 300: 264–267PubMedCrossRefGoogle Scholar
  26. Eisenbarth GS, Jackson R, Srikanta S, Powers A, Buse J, Mori H (1984) Utilization of monoclonal antibody techniques to study type I (insulin dependent) diabetes mellitus. In: Andreani D, Di Mario U, Federlin KF, Heding LG (eds) Immunology of diabetes. Kimpton Medical, London, pp 143–157Google Scholar
  27. Galfre G, Milstein C, Wright B (1979) Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse I. Nature 277: 131–133PubMedCrossRefGoogle Scholar
  28. Gledhill RM, Mirza IH, Keller U, Leslie RDG, Norman MR, Wilkin TJ (1987) Production of human monoclonal autoantibodies to insulin. Diabetologia 30: 524AGoogle Scholar
  29. Gray IP, Siddle K, Frank BH, Hales CN (1987) Characterization and use in immunoradiometric assays of monoclonal antibodies directed against human proinsulin. Diabetes 36: 684–688PubMedCrossRefGoogle Scholar
  30. Grimaldi KA, Hutton JC, Siddle K (1987) Production and characterization of monoclonal antibodies to insulin secretory granule membranes. Biochem J 245: 557–566PubMedGoogle Scholar
  31. Hari J, Yokono K, Yonezawa K, Amano K, Yaso S, Shii K, Imamura Y, Baba S (1986) Immunochemical characterization of antiislet cell surface monoclonal antibody from non-obese diabetic mice. Diabetes 35: 517–522PubMedCrossRefGoogle Scholar
  32. Haspel MV, Onodera T, Prabhakar BS, Mlintock PR, Essani K, Ray UR, Yagihashi S, Notkins AL (1983) Multiple organ-reactive monoclonal autoantibodies. Nature 304: 73–76PubMedCrossRefGoogle Scholar
  33. Kaplan DR, Colca JR, Maniel ML (1983) Insulin as a surface marker on isolated cells from rat pancreatic islets. J Cell Biol 97: 453–457CrossRefGoogle Scholar
  34. Kearney JF, Radbruch AD, Liezegang B, Rajewsky K (1979) A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 123: 1548–1550PubMedGoogle Scholar
  35. Keilacker H, Dietz H, Witt S, Woltanski KP, Berling R, Ziegler M (1986) Kinetic properties of monoclonal insulin antibodies. Biomed Biochim Acta 45: 1093–1102PubMedGoogle Scholar
  36. Koevary S, Williams D, Williams R, Chick WJ (1985) Passive transfer of diabetes from BB/W to Wistar-Furth rats. J Clin Invest 75: 1904–1907PubMedCrossRefGoogle Scholar
  37. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497PubMedCrossRefGoogle Scholar
  38. Larsson LI, Nielsen JH, Hutton JC, Madsen OD (1989) Pancreatic hormones are expressed on the surfaces of human and rat islet cells through exocytotic sites. Eur J Cell Biol 48: 45–51PubMedGoogle Scholar
  39. Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom AJ, Gamble DR (1976) Islet cell antibodies in diabetes mellitus. Lancet 2: 1273–1276PubMedCrossRefGoogle Scholar
  40. Lernmark Å (1987) Islet cell antibodies. Diabetic Med 4: 285–292PubMedCrossRefGoogle Scholar
  41. Lernmark Å, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380PubMedCrossRefGoogle Scholar
  42. Lernmark Å, Baekkeskov S, Dyrberg T, Gerling I, Marner B, Papadopoulos G, Svenningsen A, Binder C, Christy M, Nerup J, Mandrup-Poulsen T (1984) Pathogenesis of type 1 diabetes mellitus. In: Labrie F, Proulx L (eds) Endocrinology. Elsevier Science, Amsterdam, pp 92–96Google Scholar
  43. Mauish AC, Irvine WJ, Baines EW, Duncan LJ (1974) Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 2: 1529–1531Google Scholar
  44. Maclaren NK, Elder ME, Robbins VW, Riley WJ (1983) Autoimmune diathesis and T lymphocyte immunoincompetences in BB rat. Metabolism 32 [Suppl 1]: 92–96PubMedCrossRefGoogle Scholar
  45. Madsen OD (1987) Proinsulin-speciiic monoclonal antibodies. Immunocytochemical application as p cell markers and as probes for conversion. Diabetes 36: 1203–1211PubMedGoogle Scholar
  46. Madsen OD, Cohen RM, Fitch FW, Rubenstein AH, Steiner DF (1983a) The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure. Endocrinology 113: 2135–2144PubMedCrossRefGoogle Scholar
  47. Madsen OD, Carroll RJ, Steiner DF (1983b) Monoclonal antibodies against rat islet cells.Metabolism 32 [Suppl 1]: 165–166Google Scholar
  48. Madsen OD, Frank BH, Steiner DF (1984) Human proinsulin-speciiic antigenic determinants identified by monoclonal antibodies. Diabetes 33: 1012–1016PubMedCrossRefGoogle Scholar
  49. Madsen OD, Larsson LI, Rehfeld JF, Schwartz TW, Lernmark A, Labrecque AD, Steiner DF (1986) Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol 103: 2025–2034PubMedCrossRefGoogle Scholar
  50. Madsen OD, Rehfeld J, Hoist JJ, Kofod H, Hansen B, Lernmark A (1987) CCK/Glucagon expression selectively follows an anorectic tumor phenotype formed from pluripotent transformed islet cells. J Steroid Biochem 28 [Suppl]: 128SCrossRefGoogle Scholar
  51. Madsen OD, Andersen LC, Michelsen B, Owerbach D, Larsson LI, Lernmark A, Steiner DF (1988) Tissue-specific expression of transfected human insulin genes in pluripotent clonal rat insulinoma lines induced during passage in vivo. Proc Natl Acad Sci USA 85: 6652–6656PubMedCrossRefGoogle Scholar
  52. Makino S, Kunimoto R, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese diabetic strain of mice. Exp Animals 29: 1–13Google Scholar
  53. Marliss EB (1983) Workshop on the spontaneously diabetic BB rat. Metabolism 32 [Suppl 1]: 1–166PubMedCrossRefGoogle Scholar
  54. Maruyama T, Takei I, Yanagawa T, Takahashi T, Asaba Y, Kataoka K, Ishii T (1988) Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice. Diabetes Res 7: 93–96PubMedGoogle Scholar
  55. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS (1985) “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 34: 617–619PubMedCrossRefGoogle Scholar
  56. Nerup J, Mandrup-Poulsen T, Mølvig J (1987) The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metab Rev 3: 779–802PubMedCrossRefGoogle Scholar
  57. Oie HK, Gazdar AF, Minna JD, Weir G, Baylin SB (1983) Clonal analysis of insulin and somatostatin secretion and L-dopa decarboxylase expression by a rat islet cell tumor. Endocrinology 112:1070–1075PubMedCrossRefGoogle Scholar
  58. Orci L, Ravazzola M, Amherdt M, Madsen O, Vassalli JD, Perrelet A (1985) Direct identification of prohormone conversion site in insulin-secreting cells. Cell 42: 671–681PubMedCrossRefGoogle Scholar
  59. Orci L, Ravazzola M, Amherdt M, Madsen O, Perrelet A, Vassalli JD, Anderson RGW (1986) Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol 103: 2273–2281PubMedCrossRefGoogle Scholar
  60. Orci L, Ravazzolla M, Amherdt M, Perrelet A, Powell SK, Quinn DL, Moore HPH (1987a) The trans-most cisternae of the Golgi complex: a compartment for sorting of secretory and plasma membrane proteins. Cell 51: 1039–1051PubMedCrossRefGoogle Scholar
  61. Orci L, Ravazzola M, Storch MJ, Anderson RGW, Vassalli JD, Perrelet A (1987b) Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated secretory vesicles. Cell 49: 865–868PubMedCrossRefGoogle Scholar
  62. Palmer JP, Asplin CM, demons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339PubMedCrossRefGoogle Scholar
  63. Poussier P, Dayer-Metroz MD (1988) Monoclonal islet cell antibodies. In: Shafrir E, Renold AE (eds) Frontiers in diabetes research. Lessons from animal diabetes II John Libbey, London, pp 46–51Google Scholar
  64. Poussier P, Legendre C, Wood P, Guttmann RD, Brogren C-H (1986) Identification of a common epitope on the surface of rat islet cells and thymic T lymphocytes using monoclonal antibody (MAB) produced from the BB-rat. Diabetes 35 [Suppl] 1: 25AGoogle Scholar
  65. Prabhakar BS, Saegusa J, Onodera T, Notkins AL (1984) Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133: 2815–2817PubMedGoogle Scholar
  66. Rabinovitch A, Mackay P, Ludvigsson J, Lernmark A (1984) A prospective analysis of islet cell cytotoxic antibodies in insulin-dependent diabetic children: transient effects of plasmapheresis. Diabetes 33: 224–228PubMedCrossRefGoogle Scholar
  67. Sai P, Maurel C, Kremer M, Barriere P (1984) Monoclonal anti-islet cell autoantibodies from C57BLK db/db diabetic mice. Hybridoma 3: 131–139PubMedCrossRefGoogle Scholar
  68. Schatz DA, Barrett DJ, Maclaren NK, Riley WJ (1988) Polyclonal nature of islet cell antibodies in insulin dependent diabetes. Autoimmunity 1: 45–50PubMedCrossRefGoogle Scholar
  69. Schroer JA, Bender T, Feldmann RJ, Kim KJ (1983) Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol 14: 693–700CrossRefGoogle Scholar
  70. Schulman M, Wilde CD, Köhler G (1978) A better cell line for making hybridomas secreting specific antibodies. Nature 276: 269–270CrossRefGoogle Scholar
  71. Storch MJ, Petersen KG, Licht T, Kerp L (1985) Recognition of human insulin and proinsulin by monoclonal antibodies. Diabetes 34: 808–811PubMedCrossRefGoogle Scholar
  72. Srikanta S, Eisenbarth GS (1986) Islet cell antigens. Initial studies of their biology and function. Mol Biol Med 3: 113–127PubMedGoogle Scholar
  73. Takei I, Maruyama T, Taniyama M, Kataoka K (1986) Humoral immunity in the NOD mouse. In: Tarui S, Tochino Y, Nonaka K (eds) Insulitis and type 1 diabetes. Lessons from the NOD mouse. Academic Press, Tokyo, pp 101–110Google Scholar
  74. Teng NNH, Lam KS, Riera FC, Kaplan HS (1983) Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci USA 80: 7308–7312PubMedCrossRefGoogle Scholar
  75. Uchigata Y, Spitalnik SL, Tachiwaki O, Salata KF, Notkins AL (1987) Pancreatic islet cell surface glycoproteins containing Galßl-4GlAc-R identified by a cototoxic monoclonal auto-antibody. J Exp Med 165: 124–139PubMedCrossRefGoogle Scholar
  76. Vardi P, Dibella EE, Pasquarello TJ, Srikanta S (1987) Islet cell autoantibodies: pathobiology and clinical applications. Diabetes Care 10: 645–656PubMedCrossRefGoogle Scholar
  77. Wilkin T, Hoskins PJ, Armitage M, Rodier M, Casey C, Diaz JL, Pyke DA, Lesley RDG (1985) Value of insulin autoantibodies as serum markers for insulin dependent diabetes mellitus. Lancet 1: 480–481PubMedCrossRefGoogle Scholar
  78. Wilkin T, Kiesel U, Diaz JL, Burkart V, Korb H (1986) Auto-antibodies to insulin as serum markers for autoimmune insulitis. Diabetes Res 3: 173–174PubMedGoogle Scholar
  79. Witt S, Hehmke B, Dietz H, Ziegler B, Hildmann W, Ziegler M (1985) Complement-dependent cytotoxicity of monoclonal antibodies against islet cells. Biomed Biochim Acta 44: 117–121PubMedGoogle Scholar
  80. Witt VS, Dietz H, Ziegler B, Keilacker H, Ziegler M (1988) Erzeugung und Anwendung monoklonaler Glucagon-und Insulinantikörper-Reduktion des Pankreasinsulins bei Ratten durch Behandlung mit komplettem Freundschen Adjuvans. Acta Histochem [Suppl] 35: 217–223Google Scholar
  81. Yokono K, Shii K, Hari J, Yaso S, Imamura Y, Ejiri K, Ishihara K, Fujii S, Kazumi T, Taniguchi H, Baba S (1984) Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice. Diabetologia 26: 379–385PubMedCrossRefGoogle Scholar
  82. Yokono K, Amano K, Suenaga K, Hari J, Shii K, Yaso S, Yonezawa K, Imamura Y, Baba S (1986) Effect of antiserum to monoclonal anti-islet cell surface antibody on pancreatic insulitis in non-obese diabetic mice. Diab Res Clin Pract 1: 315–321CrossRefGoogle Scholar
  83. Yoon JW, Shin SY, Bachurski CJ (1984) Hybridomas from lymphocytes of normal mice produce monoclonal autoantibodies. Lancet 2: 641PubMedCrossRefGoogle Scholar
  84. Ziegler M, Ziegler B, Hehmke B (1984) Severe hyperglycemia caused by autoimmunization to beta cells in rat. Diabetologia 27: 163–165PubMedCrossRefGoogle Scholar
  85. Ziegler M, Teneberg S, Witt S, Ziegler B, Hehmke B, Kohnert KD, Egeberg J, Karlsson KA, Lernmark Å (1988) Islet β-cytotoxic monoclonal antibody against glycolipids in experimental diabetes induced by low dose streptozotocin and Freund’s adjuvant. J Immunol 140: 4144–4150PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1990

Authors and Affiliations

  1. 1.Hagedorn Research LaboratoryGentofteDenmark

Personalised recommendations